$AKBA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Akebia Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Akebia Therapeutics, Inc.. Get notifications about new insider transactions in Akebia Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Option Exercise | A | 3.37 | 20,100 | 67,737 | 20,100 | ||
| Jun 03 2021 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Grant | A | 0.00 | 13,700 | 0 | 91,100 | 77.4 K to 91.1 K (+17.70 %) | |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | SVP, CCO | Sell | S | 3.40 | 952 | 3,237 | 137,025 | 138 K to 137 K (-0.69 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Spellman David A | SVP, CFO and Treasu ... | Sell | S | 3.40 | 790 | 2,686 | 76,802 | 77.6 K to 76.8 K (-1.02 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 1,060 | 3,604 | 272,303 | 273.4 K to 272.3 K (-0.39 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Sell | S | 3.40 | 1,211 | 4,117 | 265,550 | 266.8 K to 265.6 K (-0.45 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Sell | S | 3.40 | 4,109 | 13,971 | 1,152,153 | 1.2 M to 1.2 M (-0.36 %) |
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Sell | S | 3.40 | 1,081 | 3,675 | 170,761 | 171.8 K to 170.8 K (-0.63 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Spellman David A | SVP, CFO and Treasu ... | Grant | A | 0.00 | 7,592 | 0 | 77,592 | 70 K to 77.6 K (+10.85 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Grant | A | 0.00 | 9,152 | 0 | 137,977 | 128.8 K to 138 K (+7.10 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 10,192 | 0 | 273,363 | 263.2 K to 273.4 K (+3.87 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Grant | A | 0.00 | 11,648 | 0 | 266,761 | 255.1 K to 266.8 K (+4.57 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 39,520 | 0 | 1,156,262 | 1.1 M to 1.2 M (+3.54 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Grant | A | 0.00 | 10,400 | 0 | 171,842 | 161.4 K to 171.8 K (+6.44 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Option Exercise | A | 3.46 | 110,000 | 380,600 | 110,000 | |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Sell | S | 3.40 | 6,749 | 22,920 | 128,825 | 135.6 K to 128.8 K (-4.98 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Grant | A | 0.00 | 62,000 | 0 | 135,574 | 73.6 K to 135.6 K (+84.27 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Option Exercise | A | 3.46 | 110,000 | 380,600 | 110,000 | |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 7,976 | 27,087 | 263,171 | 271.1 K to 263.2 K (-2.94 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 3.40 | 6,309 | 21,426 | 271,147 | 277.5 K to 271.1 K (-2.27 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 62,000 | 0 | 277,456 | 215.5 K to 277.5 K (+28.78 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Option Exercise | A | 3.46 | 110,000 | 380,600 | 110,000 | |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Sell | S | 3.40 | 7,945 | 26,982 | 255,113 | 263.1 K to 255.1 K (-3.02 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Sell | S | 3.40 | 6,602 | 22,421 | 263,058 | 269.7 K to 263.1 K (-2.45 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Grant | A | 0.00 | 62,000 | 0 | 269,660 | 207.7 K to 269.7 K (+29.86 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Option Exercise | A | 3.46 | 120,000 | 415,200 | 120,000 | |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Sell | S | 3.40 | 7,558 | 25,668 | 161,442 | 169 K to 161.4 K (-4.47 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Grant | A | 0.00 | 70,000 | 0 | 169,000 | 99 K to 169 K (+70.71 %) |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Cotreau Violetta | SVP, Chief Accounti ... | Option Exercise | A | 3.46 | 44,200 | 152,932 | 44,200 | |
| Mar 02 2021 | AKBA | Akebia Therapeutic ... | Cotreau Violetta | SVP, Chief Accounti ... | Grant | A | 0.00 | 26,000 | 0 | 38,900 | 12.9 K to 38.9 K (+201.55 %) |
| Feb 18 2021 | AKBA | Akebia Therapeutic ... | ZUMWALT LEANNE M | Option Exercise | A | 4.87 | 80,200 | 390,574 | 80,200 | ||
| Jul 02 2020 | AKBA | Akebia Therapeutic ... | Spellman David A | SVP, CFO and Treasu ... | Option Exercise | A | 13.58 | 280,000 | 3,802,400 | 280,000 | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Sell | S | 12.10 | 4,567 | 55,261 | 37,833 | 42.4 K to 37.8 K (-10.77 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Grant | A | 0.00 | 13,700 | 0 | 42,400 | 28.7 K to 42.4 K (+47.74 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Sell | S | 12.08 | 4,567 | 55,169 | 38,864 | 43.4 K to 38.9 K (-10.52 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Grant | A | 0.00 | 13,700 | 0 | 43,431 | 29.7 K to 43.4 K (+46.08 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Sell | S | 12.05 | 4,567 | 55,032 | 24,133 | 28.7 K to 24.1 K (-15.91 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Grant | A | 0.00 | 13,700 | 0 | 28,700 | 15 K to 28.7 K (+91.33 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Grant | A | 0.00 | 13,700 | 0 | 38,629 | 24.9 K to 38.6 K (+54.96 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Grant | A | 0.00 | 13,700 | 0 | 34,886 | 21.2 K to 34.9 K (+64.67 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Grant | A | 0.00 | 13,700 | 0 | 31,143 | 17.4 K to 31.1 K (+78.54 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Grant | A | 0.00 | 13,700 | 0 | 77,400 | 63.7 K to 77.4 K (+21.51 %) | |
| Jun 02 2020 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Sell | S | 11.58 | 6,426 | 74,413 | 73,574 | 80 K to 73.6 K (-8.03 %) |
| Apr 07 2020 | AKBA | Akebia Therapeutic ... | Wolf Myles | Option Exercise | A | 7.09 | 80,200 | 568,618 | 80,200 | ||
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Option Exercise | A | 8.87 | 120,000 | 1,064,400 | 120,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Sell | S | 8.70 | 6,972 | 60,656 | 204,960 | 211.9 K to 205 K (-3.29 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Operatin ... | Grant | A | 0.00 | 65,000 | 0 | 211,932 | 146.9 K to 211.9 K (+44.24 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Option Exercise | A | 8.87 | 105,000 | 931,350 | 105,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Sell | S | 8.70 | 7,050 | 61,335 | 212,756 | 219.8 K to 212.8 K (-3.21 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, Chief Legal Of ... | Grant | A | 0.00 | 62,000 | 0 | 219,806 | 157.8 K to 219.8 K (+39.29 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Amello Jason | SVP, CFO & Treasure ... | Option Exercise | A | 8.87 | 45,000 | 399,150 | 45,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Amello Jason | SVP, CFO & Treasure ... | Sell | S | 8.70 | 6,976 | 60,691 | 144,642 | 151.6 K to 144.6 K (-4.60 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Amello Jason | SVP, CFO & Treasure ... | Grant | A | 0.00 | 30,000 | 0 | 151,618 | 121.6 K to 151.6 K (+24.67 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Option Exercise | A | 8.87 | 85,000 | 753,950 | 85,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Sell | S | 8.70 | 3,454 | 30,050 | 84,679 | 88.1 K to 84.7 K (-3.92 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Grant | A | 0.00 | 30,000 | 0 | 88,133 | 58.1 K to 88.1 K (+51.61 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 8.87 | 403,600 | 3,579,932 | 403,600 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 237,400 | 0 | 1,026,632 | 789.2 K to 1 M (+30.08 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Option Exercise | A | 8.87 | 105,500 | 935,785 | 105,500 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Grant | A | 0.00 | 62,000 | 0 | 99,000 | 37 K to 99 K (+167.57 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Option Exercise | A | 8.87 | 94,000 | 833,780 | 94,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Grant | A | 0.00 | 55,000 | 0 | 80,000 | 25 K to 80 K (+220.00 %) |
| Nov 22 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Buy | P | 3.43 | 5,800 | 19,894 | 29,731 | 23.9 K to 29.7 K (+24.24 %) | |
| Nov 22 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Buy | P | 3.52 | 15,000 | 52,800 | 28,700 | 13.7 K to 28.7 K (+109.49 %) | |
| Nov 22 2019 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Buy | P | 3.58 | 27,000 | 96,660 | 37,000 | 10 K to 37 K (+270.00 %) |
| Nov 21 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | P | 3.44 | 50,000 | 172,000 | 887,732 | 837.7 K to 887.7 K (+5.97 %) |
| Nov 21 2019 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Buy | P | 3.41 | 50,000 | 170,500 | 63,700 | 13.7 K to 63.7 K (+364.96 %) | |
| Sep 04 2019 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Option Exercise | A | 4.13 | 250,000 | 1,032,500 | 250,000 | |
| Sep 04 2019 | AKBA | Akebia Therapeutic ... | Burke Steven Keith | SVP, Chief Medical ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Grant | A | 0.00 | 13,700 | 0 | 13,700 | 0 to 13.7 K | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Grant | A | 0.00 | 13,700 | 0 | 24,929 | 11.2 K to 24.9 K (+122.01 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Grant | A | 0.00 | 13,700 | 0 | 58,619 | 44.9 K to 58.6 K (+30.50 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Grant | A | 0.00 | 13,700 | 0 | 21,186 | 7.5 K to 21.2 K (+183.01 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Grant | A | 0.00 | 13,700 | 0 | 15,000 | 1.3 K to 15 K (+1,053.85 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Grant | A | 0.00 | 13,700 | 0 | 23,931 | 10.2 K to 23.9 K (+133.91 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Grant | A | 0.00 | 13,700 | 0 | 17,443 | 3.7 K to 17.4 K (+366.02 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Canute Scott A | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Canute Scott A | Grant | A | 0.00 | 13,700 | 0 | 13,700 | 0 to 13.7 K | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Grant | A | 0.00 | 13,700 | 0 | 13,700 | 0 to 13.7 K | |
| Jun 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 287,000 | 134,890 | 0 | |
| Jun 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 287,000 | 134,890 | 836,232 | 549.2 K to 836.2 K (+52.25 %) |
| Jun 03 2019 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Option Exercise | A | 4.45 | 250,000 | 1,112,500 | 250,000 | |
| Jun 03 2019 | AKBA | Akebia Therapeutic ... | Faulkingham Dell | CCO | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Jain Rita | SVP, Chief Medical ... | Sell | D | 7.70 | 4,409 | 33,949 | 96,332 | 100.7 K to 96.3 K (-4.38 %) |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Business ... | Sell | D | 7.70 | 11,909 | 91,699 | 146,932 | 158.8 K to 146.9 K (-7.50 %) |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, CLO & Secretar ... | Sell | D | 7.70 | 11,929 | 91,853 | 154,806 | 166.7 K to 154.8 K (-7.15 %) |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Sell | D | 7.70 | 6,075 | 46,778 | 55,324 | 61.4 K to 55.3 K (-9.89 %) |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Amello Jason | SVP, CFO & Treasure ... | Sell | D | 7.70 | 13,148 | 101,240 | 118,618 | 131.8 K to 118.6 K (-9.98 %) |
| Mar 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 7.28 | 350,000 | 2,548,000 | 350,000 | |
| Mar 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 239,500 | 0 | 614,382 | 374.9 K to 614.4 K (+63.89 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Option Exercise | A | 16.17 | 18,716 | 302,638 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Morrison Jodie Pope | Director | Grant | A | 0.00 | 44,919 | 0 | 44,919 | 0 to 44.9 K |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 15.26 | 11,229 | 171,355 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 12.48 | 18,716 | 233,576 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 11,229 | 0 | 11,229 | 0 to 11.2 K |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 15.26 | 11,229 | 171,355 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 12.48 | 18,716 | 233,576 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,231 | 0 | 10,231 | 0 to 10.2 K |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Director | Option Exercise | A | 19.56 | 18,716 | 366,085 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Enyedy Mark J | Director | Grant | A | 0.00 | 3,743 | 0 | 3,743 | 0 to 3.7 K |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ADAMS ADRIAN | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 16.17 | 18,716 | 302,638 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 7,486 | 0 | 7,486 | 0 to 7.5 K |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Payment of Exercise | F | 8.94 | 11,928 | 106,636 | 30,229 | 42.2 K to 30.2 K (-28.29 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Jain Rita | SVP, Chief Medical ... | Payment of Exercise | F | 8.94 | 8,659 | 77,411 | 20,741 | 29.4 K to 20.7 K (-29.45 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Hadas Nicole R. | SVP, General Counse ... | Payment of Exercise | F | 8.94 | 20,175 | 180,365 | 101,284 | 121.5 K to 101.3 K (-16.61 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Dahan Michel | SVP, Chief Business ... | Payment of Exercise | F | 8.94 | 23,385 | 209,062 | 93,841 | 117.2 K to 93.8 K (-19.95 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO & President | Payment of Exercise | F | 8.94 | 135,697 | 1,213,131 | 374,617 | 510.3 K to 374.6 K (-26.59 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Amello Jason | SVP, CFO & Treasure ... | Payment of Exercise | F | 8.94 | 22,235 | 198,781 | 66,501 | 88.7 K to 66.5 K (-25.06 %) |
| Aug 29 2018 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 8.25 | 25,000 | 206,250 | 25,000 | ||
| Jul 12 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 100,000 | 47,000 | 287,000 | |
| Jul 12 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 100,000 | 47,000 | 510,314 | 410.3 K to 510.3 K (+24.37 %) |
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | WYZGA MICHAEL S | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Renaud Ronald C JR | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Nash Duane | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | GOWEN MAXINE | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Clayman Michael D. | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Canute Scott A | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 14.30 | 126,300 | 1,806,090 | 126,300 | |
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 88,900 | 0 | 408,814 | 319.9 K to 408.8 K (+27.79 %) |